<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-Q
FOR THE QUARTERLY PERIOD ENDED JANUARY 31, 1996 AND IS QUALIFIED IN ITS ENTIRETY
BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000316253
<NAME> ENZO BIOCHEM, INC
<MULTIPLIER> 1,000
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          JUL-31-1996
<PERIOD-START>                             AUG-01-1995
<PERIOD-END>                               JAN-31-1996
<CASH>                                          16,369
<SECURITIES>                                         0
<RECEIVABLES>                                   22,338
<ALLOWANCES>                                   (4,788)
<INVENTORY>                                      2,408
<CURRENT-ASSETS>                                37,262
<PP&E>                                          18,838
<DEPRECIATION>                                 (5,203)
<TOTAL-ASSETS>                                  74,362
<CURRENT-LIABILITIES>                            4,816
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           215
<OTHER-SE>                                      63,616
<TOTAL-LIABILITY-AND-EQUITY>                    74,362
<SALES>                                         16,564
<TOTAL-REVENUES>                                16,564
<CGS>                                            7,058
<TOTAL-COSTS>                                    8,139
<OTHER-EXPENSES>                                 6,785
<LOSS-PROVISION>                                 1,354
<INTEREST-EXPENSE>                               (764)
<INCOME-PRETAX>                                  2,131
<INCOME-TAX>                                       670
<INCOME-CONTINUING>                              1,461
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     1,461
<EPS-PRIMARY>                                      .07
<EPS-DILUTED>                                      .07